Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Journal of Clinical Investigation
|
April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy
Yeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Nature Communications
|
December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab
Theodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Nature Communications
|
February 2, 2020
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
Giulia Parisi, Justin D Saco, Felix B Salazar, et al.
Nature Cancer
|
August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Cancer Discovery
|
May 30, 2020
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade
Davis Y Torrejon, Gabriel Abril-Rodriguez, Ameya S Champhekar, et al.
Nature Cancer
|
February 5, 2022
Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Scientific Reports
|
September 14, 2024
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Elisabeth Roider, Alexandra I T Lakatos, Alicia M McConnell, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species
Elisabeth Roider, Alexandra I T Lakatos, Alicia M McConnell, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Journal of Clinical Investigation
|
April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy
Yeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Nature Communications
|
December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab
Theodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Nature Communications
|
February 2, 2020
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
Giulia Parisi, Justin D Saco, Felix B Salazar, et al.
Nature Cancer
|
August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Cancer Discovery
|
May 30, 2020
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade
Davis Y Torrejon, Gabriel Abril-Rodriguez, Ameya S Champhekar, et al.
Nature Cancer
|
February 5, 2022
Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Scientific Reports
|
September 14, 2024
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Elisabeth Roider, Alexandra I T Lakatos, Alicia M McConnell, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species
Elisabeth Roider, Alexandra I T Lakatos, Alicia M McConnell, et al.
Page
of 4